Practice Areas & Industries: Motley Rice

 





Group Profile Lawyers in this Group Offices Locations for this Group
 

Practice/Industry Group Overview

The Motley Rice Medical practice group represents individuals harmed by drugs, defective medical devices, nursing home abuse or neglect, or medical malpractice. Our attorneys are positioned to take on medical industry giants and follow the trail of inadequate medical care, corporate wrongdoing, or a hasty marketing push for a medical drug or product. As the business and science behind medical industries grow increasingly complex, we strongly advocate for those suffering from a failure to provide sufficient medical care, research and product development.

Potentially Dangerous Drug Lawsuits
Drug manufacturers sometimes fail to properly research their products or inform patients and health care providers about all of the risks and side effects associated with their drugs. Motley Rice's Medical practice group has experience litigating prescription drug lawsuits and the resources necessary to defend the legal rights of people injured by potentially dangerous drugs. Motley Rice attorneys have litigated cases or are currently litigating or interested in representing clients in drug cases regarding the following prescription drugs:

  • Accutane®
  • Actos®
  • Avandia®
  • Byetta®, Januvia®, Janumet® & Victoza®
  • Crestor®
  • Denture Cream®
  • Digitek®
  • Drugs Associated with
  • Stevens-Johnson Syndrome®
  • Effexor
  • Fosamax®
  • Lipitor®
  • NuvaRing®
  • Pradaxa®
  • Tekturna®
  • Testosterone Replacement Therapy
  • Topamax®
  • Tylenol®
  • Wellbutrin®
  • Yasmin®
  • Yaz®
  • Zoloft®
  • Zyban®

Medical Device Lawsuits
Many have suffered serious injury or wrongful death from using medical devices that manufacturers did not adequately test before selling to the general population. Motley Rice Medical team understands the complex legal, scientific, and medical aspects of medical device lawsuits and has experience litigating on behalf of those who have experienced serious injury or suffered wrongful death related to the use of a faulty medical device. Our lawyers are litigating cases or are interested in representing clients in medical device cases regarding the following potentially defective medical devices:

  • Biomet M2a-Magnum™ metal-on-metal hip replacements
  • Composix® Kugel® Mesh Hernia Repair Patch
  • DePuy Hip Replacements
  • Dialysis Products
  • Mirena® IUD
  • Stryker® Rejuvenate Hip Implant
  • Synthes Synex II® Central Body Components
  • Transvaginal/Pelvic Mesh
  • Wright Medical Technology Hip Replacements
  • Zimmer Durom® Cup Hip Replacement

Nursing Home Abuse and Neglect Lawsuits
Nearly two million Americans currently live in nursing homes, and the increase in abuse, neglect and malpractice against the elderly has become a national concern. Abuse and neglect of our most defenseless population can take many forms, and the federal and state regulations that exist to govern the rights of nursing home and assisted living residents sometimes fail. Motley Rice's lawyers have experience litigating nursing home lawsuits and seek to protect the rights of residents while providing victims of negligence with the compensation and care to which they are entitled.


 
 
Articles Authored by Lawyers at this office:

Talcum Powder Lawsuit: Suit Alleges Talcum Powder Use Linked to Ovarian Cancer
Carmen S. Scott, March 04, 2015
In a suit filed against Johnson & Johnson, Sanofi US and a number of other talcum powder manufacturers, Motley Rice attorneys and co-counsel are asking why a common over-the-counter hygiene product that has been linked to an increased risk in ovarian cancer for more than 30 years has no warning...

Trouble with Tylenol®: Even common OTC Medication Should Be Taken With Care
Carmen S. Scott, February 18, 2015
When the risk of severe, potentially deadly skin reactions is found in association with one of the most widely used over-the-counter medications, you would think that warning the public would be a priority. But a year and a half after publishing an initial consumer update on the risk, the FDA is...

Is the Grass Really Greener for Afib Sufferers Taking Xarelto?
Fred Thompson, December 29, 2014
There’s a strong chance that my heart skipped a beat when I found out about the FDA’s approval of the new anti-clotting drug, Xarelto®. As one of more than two million Americans suffering from atrial fibrillation, a condition involving erratic heartbeats, I’m just as...

Putting on Purple this November: Recognizing Pancreatic Cancer Awareness Month
Kimberly Barone Barone Baden, November 28, 2014
Pancreatic cancer might not have the same name recognition as breast or colon cancer, but of the top 25 cancer killers today, it’s the only one with a five-year survival rate at six percent. Add to this that more than 45,000 United States citizens are diagnosed with this intrusive disease...

Discussing The Latest In Asbestos Lung Cancer Litigation
V. Brian Bevon, October 20, 2014
As many Americans are all too aware, lung cancer continues to be the leading cancer killerin both men and women in the United States. It is mainly seen as a disease of the elderly, with more than 82 percent of those suffering 60 years of age or older. This is due in part to aggressive cancers such...

Mesothelioma Awareness Day 2014: Recent Headlines Highlight That Asbestos Is Still a Relevant Issue
John E. Herrick, October 08, 2014
A couple of recent articles about renovation workers encountering asbestos while working on building modifications have recently caught my attention. And, with Mesothelioma Awareness Day coming up this Friday, September 26, 2014, I wanted to share some thoughts on asbestos, mesothelioma and the...

Morcellator Warning Only the Latest Reason FDA Should Consider Revising the 510(K) Process
Carmen S. Scott, September 02, 2014
When the FDA released a safety communication earlier this year about the laparoscopic power morcellation (LPM) procedure, many women may have been shocked to learn that this fairly common procedure for removing supposedly benign uterine fibroids could result in the rapid spread of cancer if those...